Menu

News & Blog

Newsroom and our expert advice and guidance....

The minister tasked with leading Brexit meets life science businesses

The minister tasked with leading Brexit meets life science businesses

Datatrial was represented at a meeting with Steve Baker MP this week to discuss the life science sector as part of the government’s engagement with businesses ahead of Brexit.

Steve Baker, Parliamentary Under Secretary of State at the Department for Exiting the European Union, was in Newcastle as part of the government programme to engage with UK businesses as Brexit negotiations continue.

Hosted by Newcastle University, he heard from spin-out, start up and established firms in the life science sector about their concerns and suggestions for a future outside the EU.

Steve Baker said: "My visit to Newcastle has been an excellent opportunity to hear about the priorities and challenges facing the life sciences industry as we progress with our exit from the EU.

"The UK has one of the strongest and most productive life sciences sectors in the world, and after we leave the EU we want to ensure that patients here and across Europe continue to have access to the best and most innovative medicines."

Datatrial CEO Dr Emma Banks who attended the meeting said: “Companies in the biotech and life sciences industry are facing a particularly uncertain future during the Brexit negotiations.

“Datatrial develop software to improve the clinical research process and are about to launch our new software Nucleus in Boston and Berlin as most of our customers are outside the UK. 

“One of our biggest concerns is the future of the European Medicines Agency (EMA), which is crucial to British companies in our industry. The EMA is currently headquartered in London but will need to move to remain a part of the EU to fulfil its regulatory duties. This could lead to significant confusion and upheaval, particularly in relation to the influence of the MHRA.”

Martin Cox, Head of Enterprise Services at Newcastle University who hosted the round table discussion added: “The companies were very clear about their areas of concern particularly around regulation, and ensuring that we can continue to attract the best scientific minds and innovators to the UK.

“They also highlighted the importance of certainty around timescales and the environment in which they operate.”

Back to news & blog